Clinical Lead, Early Clinical and Experimental Therapeutics
Sanofi
About this role
A Clinical Lead in Early Clinical and Experimental Therapeutics at Sanofi drives translation from preclinical development through early clinical development across multiple therapeutic modalities. The role is based in the Translational Medicine Unit and focuses on human target validation, experimental model validation, and early proof-of-mechanism/proof-of-concept studies while partnering closely with cross-functional R&D teams.
Skills
Qualifications
About Sanofi
sanofi.comSanofi is a research & development-driven, AI-powered healthcare biopharma company committed to improving lives through innovative medicines & vaccines.
Recent company news
Sanofi (NASDAQ:SNY) Hits New 52-Week Low - Should You Sell?
21 hours ago
Alchemab Therapeutics lures Sanofi exec to be its CBO
2 days ago
Sanofi: An Undervalued Stock For Long-Term Dividend Growth Investors (SNY)
2 days ago
NANOBODY® Technology Platform
Aug 26, 2025
Is Sanofi (ENXTPA:SAN) Now An Opportunity After A 25.8% One Year Share Price Slide?
3 days ago
About Sanofi
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Sanofi.
Salary
$201k – $290k
per year
More jobs at Sanofi
Similar Jobs
Clinical Development Medical Director- Inflammation
GSK plc
Medical Senior Director – Early Clinical Development – Inflammation
Amgen
Clinical Director (Principal Scientist), Translational Medicine, Immunology
MSD
Senior Medical Director, Translational Medicine & Early Clinical Development
Madrigal Pharmaceuticals
Principal Scientist – Translational Science – Neurodegeneration
GSK plc
Medical Director, Kidney Disease, Early Clinical Development CVRM
AstraZeneca